AKT1 and neoplasm: We hypothesize that, like OIS, AIS is a reversible tumor-suppressive mechanism, and understanding how it is overcome will identify mechanisms of tumorigenesis and therapeutic resistance in the 38% of human solid cancers with deregulated PI3K/AKT/mTORC1 activity [3].